ASTRAZENECA Q2 FY27 ; TOTAL REVENUE FROM OPERATIONS UP 30.41% AT ₹729.10 CR (YOY), UP 6.78% (QOQ)

ONCOLOGY Q2 REVENUE UP 27.83% AT ₹508.50 CR (YOY) BIOPHARMACEUTICALS Q2 REVENUE UP 26.97% AT ₹161.00 CR (YOY) RARE DISEASES Q2 REVENUE UP 436.84% AT ₹20.40 CR (YOY)

AstraZeneca Pharma India Ltd

Open attachment

← Back to feed